Track the DIASORIN SPA stock price and the full management transaction log of the company, a listed equity based in Italy. Shares are quoted on the IT market, under the authority of Consob. Operating in the Health Care sector, DIASORIN SPA has published 13 reports. Market capitalisation: €3.5bn. The latest transaction was disclosed on 23 July 2026 (Purchase). All data is openly available.
13
Insider Decl.
n/a
Thresholds
€151m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate DIASORIN SPA Hold (neutral), based on 14 analysts. Average price target: €70.45.
33Σ signal
Buys €151mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,560 of 29,053 companies
61.7
score / 100
Value
58
Quality
66
FCF yld5.5%
Earn yld4.1%
EV/EBITDA12.5x
ROE9.2%
Gross mgn65%
Net mgn13%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3 shares@ €66.960.0000% mcap0.0% of flowShareXMILISINISIN IT0003492391CONSOB:175961
13 of 13 declarations
About DIASORIN SPA
DIASORIN SPA is a company specializing in in vitro diagnostics, providing solutions for the detection of infectious diseases and tumor markers. It is listed on the XMIL market.